Navigation Links
Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
Date:10/13/2008

robiological Technologies, Inc.

Neurobiological Technologies, Inc., (Nasdaq: NTII) is a biopharmaceutical company focused on developing novel, first-in-class agents for central nervous system conditions and other serious unmet medical needs. The Company's most advanced product candidate, Viprinex(TM) (ancrod), is in Phase 3 clinical testing as a novel investigational drug for the treatment of acute ischemic stroke. Viprinex has multiple mechanisms of action and is specifically designed to extend the time period that patients can be treated after the onset of a stroke. NTI also has early-stage development programs for Alzheimer's and Huntington's diseases, rights to receive payments on an approved drug for Alzheimer's disease and an investigational drug in Phase 3 trials for brain swelling.

NOTE: Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including uncertainties regarding the development of Viprinex for acute ischemic stroke, delays or other problems with our clinical trials, including the inability to enroll patients at anticipated rates, the outcome of the interim analysis, the time and costs for obtaining approval for Viprinex, and levels of future expenditures and capital resources needed to fund operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K, as updated periodically in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Actual results may differ materially from those projected. These forward-looking statements represent our judgment as of the date of the release and we undertake
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
2. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
3. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
4. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
5. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
6. ImmunoVaccine Technologies DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases
7. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
8. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
9. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
10. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
11. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... NEW YORK , July 21, 2014  EHE ... physical exams with a nationwide physician network, today announced ... Las Vegas, NV has been named ... in the Las Vegas region ... to help proactively maintain their health. ...
(Date:7/21/2014)... New York , July 21, 2014 ... report published by Transparency Market Research "E-Clinical Solution Software ... Forecast, 2014 - 2020," the global microfluidic device market ... is expected to grow at a CAGR of 13.8% ... of USD 6,515.3 million in 2020. Browse ...
(Date:7/21/2014)... LAS VEGAS , July 21, 2014 By ... Division will conduct an online sale of ophthalmic and optical ... Las Vegas -based eyewear specialists American Optical Services LLC. ... and will close in rapid succession, live auction style, ... the various assets being offered will be held July 25 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
(Date:7/22/2014)... 22, 2014 Dr. Allen Kamrava, colorectal ... launch of a new website dedicated to the diagnosis ... be found at DrKamrava.com . , “With this ... a knowledgeable and trustworthy source for various colorectal ... hemorrhoids, fissures, gallstones, colon cancer, hernias, or more, patients ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... online marketing training course that takes a comprehensive, step-by-step ... scale an online marketing venture has just been released ... Hendricks. , “In the internet marketing world if you’re ... Hendricks. “And a lot of people simply give up ...
(Date:7/22/2014)... 2014 Eating certain foods can not only ... according to two of the world’s top cosmetic dentists. ... of the Anacapa Dental Art Institute in Oxnard and Woodland ... of one’s teeth. They are specially trained to replace missing ... not seeing a dentist regularly, and about two-thirds of the ...
(Date:7/22/2014)... Kirby Lester, LLC, the leading pharmacy automation ... functionality to perform a trackable double-count for any prescription ... double-count of controlled medications is required, the KL1Plus allows ... a second count of any tablet or capsule order. ... second count up to 10 years. This function is ...
(Date:7/22/2014)... 22, 2014 Industry-leading health business information ... release of Specialty Pharmacy Trends and Strategies: 2014 ... provides a comprehensive overview of the current state of ... strategies and tactics for:, , Specialty ... utilization concerns — including details of coinsurance levels by ...
Breaking Medicine News(10 mins):Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3Health News:Info Cash 2.0: Review Of Chris Carpenter’s Online Marketing Training Released 2Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 2Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 3Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 4Health News:Ventura’s Best Cosmetic Dentists Offer 4 Tips for Improving Dental Health Through Nutrition 5Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2
... declined dramatically after the establishment of North America,s first ... the findings of a groundbreaking new study published in ... first peer-reviewed study to assess the impact of supervised ... reduction in overdose deaths in the immediate vicinity of ...
... , THURSDAY, April 21 (HealthDay News) -- For men ... don,t measure up -- success can be found in ... by Italian researchers contends. Concerned that patients were ... the penis, the researchers examined the medical literature to ...
... obese adolescents are no more likely to be depressed than ... online in the Journal of Adolescent Health , did ... psychological effects of obesity. This three-year study performed ... Policy at MassGeneral Hospital for Children (MGHfC) and the Department ...
... 21 (HealthDay News) -- Long-term use of topical corticosteroids to ... cause any major negative side effects, according to a new ... corticosteroid creams or lotions applied to the skin and this ... explained. The most common fear among parents is that these ...
... Dotinga HealthDay Reporter , THURSDAY, April 21 (HealthDay ... exposure to a class of pesticides widely used on food ... is especially noticeable in kids from a California farming region ... pesticides through their use on local crops. ...
... effects of mindfulness meditation on pain and working memory ... crucial brain wave called the alpha rhythm. This rhythm ... information, which suggests that a key value of meditation ... world. Researchers from Massachusetts General Hospital (MGH), Harvard Medical ...
Cached Medicine News:Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 2Health News:When Size Matters, Men Can Turn to Penile Extenders: Study 3Health News:Severe obesity not seen to increase risk of depression in teens 2Health News:Corticosteroid Creams Safe for Kids With Eczema: Study 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 2Health News:Pesticide Exposure in Pregnancy Linked to Lower IQ in Kids 3Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3